| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $5.21M | - | |
| CEO | 338.1K | $3.55M | - | |
| Other | 215.4K | $2.26M | - | |
| Other | 64.8K | $680.5K | - | |
| CFO | 39.6K | $416.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Pakola Steve70 | Chief Medical Officer | Sale+OE | 2,161 | $13.64 | $29,476.04 | -1.0% | - | - | |
| Jul 1, 2026 | Pakola Steve70 | Chief Medical Officer | Sale+OE | 56,333 | $12.23 | $688,755.82 | -11.7% | - | - | |
| Mar 10, 2026 | Pakola Steve70 | Chief Medical Officer | Sell | 5,124 | $10.35 | $53,033.40 | -2.0% | -30.5% | - | |
| Oct 9, 2025 | Simpson Curran66 | Chief Executive Officer | Sell | 20,811 | $12.62 | $262,634.82 | -8.8% | +25.2% | - | |
| Sep 29, 2025 | Simpson Curran66 | Chief Executive Officer | Sell | 7,624 | $10.03 | $76,468.72 | -3.1% | +45.2% | - | |
| Sep 10, 2025 | Simpson Curran66 | Chief Executive Officer | Sell | 7,734 | $10.02 | $77,494.68 | -3.1% | +32.9% | - | |
| May 12, 2025 | Mills Kenneth T.81 | Director | Sale+OE | 20,602 | $7.91 | $163,046.29 | -4.2% | -6.4% | +28.5% | |
| Oct 1, 2024 | Karabelas Argeris N73 | Director | Sale+OE | 10,000 | $10.11 | $101,052.00 | -47.0% | -29.2% | -4.3% | |
| Sep 3, 2024 | Karabelas Argeris N73 | Director | Sale+OE | 10,000 | $11.56 | $115,588.00 | -30.1% | -11.8% | -13.1% | |
| Aug 1, 2024 | Karabelas Argeris N73 | Director | Sale+OE | 10,100 | $13.51 | $136,454.00 | -22.7% | -33.6% | -38.5% |